Esperion Therapeutics, Inc. (ESPR) Reports Material Event to SEC
Filing Details Esperion Therapeutics, Inc. (NASDAQ:ESPR) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market Context…
Read more
